mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.7 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Nilotinib |
FIMM |
pan-cancer |
AAC |
0.074 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |